• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Low mortality, stroke seen with newest Edwards TAVR system: study
(Reuters) - Researchers on Sunday presented trial data showing very low mortality and stroke rates using the third generation version of Edwards Lifesciences Corp's non-invasive heart valve replacement system that could help support its U.S. approval.
Source: Reuters: Health - March 15, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Hospital websites often understate risks of new valve replacement
U.S. hospitals that offer information about a common heart valve replacement procedure often explain the benefits but rarely mention the risks - including doubled risk of stroke - according to a new study.
Source: Reuters: Health - January 15, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA approves Daiichi anti-clotting drug
(Reuters) - U.S. regulators on Thursday approved the use of a drug made by Daiichi Sankyo Co Ltd to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem.
Source: Reuters: Health - January 9, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Medtronic heart valve found to reduce death, stroke rate
(Reuters) - Medtronic Inc's CoreValve heart valve implant significantly lowered death and stroke rates in frail, elderly patients with severe aortic stenosis who were considered too ill for surgery, according to data from a late-stage clinical trial.
Source: Reuters: Health - October 29, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Edwards heart valve system good as surgery at 3 years-trial
SAN FRANCISCO (Reuters) - Patients who received the original version of Edwards Lifesciences Corp's non-invasive heart valve replacement system had a nearly identical death rate after three years as those who had open-heart surgery, with no increased risk of stroke, according to results from a clinical trial.
Source: Reuters: Health - March 11, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Edwards heart valve system good as surgery at three years: trial
SAN FRANCISCO (Reuters) - Patients who received the original version of Edwards Lifesciences Corp's non-invasive heart valve replacement system had a nearly identical death rate after three years as those who had open-heart surgery, with no increased risk of stroke, according to results from a clinical trial.
Source: Reuters: Health - March 11, 2013 Category: Consumer Health News Tags: healthNews Source Type: news